Cambiar Investors LLC Sells 12,763 Shares of Amdocs Limited (NASDAQ:DOX)

Cambiar Investors LLC lowered its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 10.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,642 shares of the technology company's stock after selling 12,763 shares during the period. Cambiar Investors LLC owned 0.10% of Amdocs worth $9,761,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. First Horizon Advisors Inc. grew its holdings in shares of Amdocs by 1.9% in the third quarter. First Horizon Advisors Inc. now owns 5,902 shares of the technology company's stock valued at $516,000 after purchasing an additional 109 shares in the last quarter. Private Trust Co. NA grew its holdings in shares of Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock valued at $27,000 after purchasing an additional 117 shares in the last quarter. Morton Community Bank grew its holdings in shares of Amdocs by 0.4% in the third quarter. Morton Community Bank now owns 36,410 shares of the technology company's stock valued at $3,185,000 after purchasing an additional 130 shares in the last quarter. Private Advisor Group LLC boosted its stake in Amdocs by 3.2% during the third quarter. Private Advisor Group LLC now owns 5,626 shares of the technology company's stock worth $492,000 after buying an additional 175 shares during the period. Finally, KFG Wealth Management LLC boosted its stake in Amdocs by 8.2% during the fourth quarter. KFG Wealth Management LLC now owns 2,496 shares of the technology company's stock worth $213,000 after buying an additional 189 shares during the period. Institutional investors own 92.02% of the company's stock.

Amdocs Trading Up 1.2 %

Shares of DOX traded up $1.07 during trading hours on Friday, reaching $88.30. 663,595 shares of the company traded hands, compared to its average volume of 648,680. The firm has a market cap of $9.97 billion, a price-to-earnings ratio of 20.49, a PEG ratio of 1.41 and a beta of 0.71. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The stock's fifty day moving average price is $85.86 and its 200 day moving average price is $86.48.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. Sell-side analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Sunday, April 20th. Investors of record on Monday, March 31st will be issued a $0.527 dividend. This is an increase from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 annualized dividend and a dividend yield of 2.39%. The ex-dividend date of this dividend is Monday, March 31st. Amdocs's payout ratio is presently 44.55%.

Analyst Ratings Changes

Several research analysts have commented on DOX shares. StockNews.com raised shares of Amdocs from a "buy" rating to a "strong-buy" rating in a research note on Wednesday, February 5th. Barclays dropped their price objective on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research note on Thursday, November 14th. Finally, Oppenheimer boosted their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.